What determines nasal carriage of Staphylococcus aureus?

Trends in Microbiology

Volumn 9, Issue 12, 2001, Pages 605-610

  Peacock, Sharon J ^a   De Silva, Ishani ^a   Lowy, Franklin D ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL ENZYME; BACTERIAL PROTEIN; LYSOSTAPHIN; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL INFECTION; BACTERIUM ADHERENCE; BACTERIUM CARRIER; COMMUNITY; ENDOCARDITIS; ENZYME RELEASE; HOSPITAL INFECTION; HUMAN; IMMUNE RESPONSE; KERATITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

CARRIER STATE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNE SYSTEM; NASAL MUCOSA; NOSE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 0035584874     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(01)02254-5     Document Type: Review

References (75)

1. An overview of nosocomial infections, including the role of the microbiology laboratory
2. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: Impact of intravascular devices and methicillin resistance
3. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus working group
4. Staphylococcus aureus infections
5. Problems with antimicrobial resistance in Gram-positive cocci
6. The relationship between the nasal staphylococcal carrier state and the incidence of post-operative compliations
7. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis
8. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis
9. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus
10. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients
11. Nasal carriage as a source of Staphylococcus aureus bacteremia
12. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients
13. Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus
14. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: Long-term results
15. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection
16. Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus
17. Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin
18. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis
19. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit
20. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus
21. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks
22. Carriage of Staphylococcus aureus: Epidemiology and clinical relevance
23. Follow-up of Staphylococcus aureus nasal carriage after 8 years: Redefining the persistent carrier state
24. Carriage of Staphylococcus aureus and beta haemolytic streptococci in relation to race
25. Carriage of Staphylococcus aureus in random samples of a normal population
26. Innate antimicrobial activity of nasal secretions
27. Bacterial adherence to nasal mucosal cells
28. The normal flora of the nose in twins
29. Staphylococcus aureus carriage in twins
30. Association between histocompatibility antigens (HLA) and nasal carriage of Staphylococcus aureus
31. Staphylococcus aureus binding to human nasal mucin
32. Healthy carriage of Staphylococcus aureus: Its prevalence and importance
33. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment
34. Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli
35. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging
36. Blood group glycolipids as epithelial cell receptors for Candida albicans
37. Effect of the ABO blood group phenotype on the Staphylococcus aureus bacterial carrier state
38. Factors enhancing adherence of toxigenic Staphylococcus aureus to epithelial cells and their possible role in sudden infant death syndrome
39. Binding of Staphylococcus aureus to fibronectin and glycolipids on corneal surfaces
40. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface
41. Many pulmonary pathogenic bacteria bind specifically to the carbohydrate sequence GalNAc-β-1-4Gal found in some glycolipids
42. Calcium- and mucin-binding proteins of staphylococci
43. Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells
44. Comparison of in vitro adherence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus to human nasal epithelial cells
45. Importance of the keratinized epithelial cell in bacterial adherence
46. Mediation of staphylococcal adherence to mucosal cells by lipoteichoic acid
47. Binding of staphylococci to mucus in vivo and in vitro
48. Nasal rejection of experimentally inoculated Staphylococcus aureus: Evidence for an immune reaction in man
49. Carriage rate of Staphylococcus aureus among patients receiving allergy injections
50. Typing of Staphylococcus aureus colonising human nasal carriers by pulsed-field gel electrophoresis
51. Coagulase and protein A polymorphisms do not contribute to persistence of nasal colonisation by Staphylococcus aureus
52. Staphylococcal infections in newborn infants: II. Report of 19 epidemics caused by an identical strain of Staphylococcus pyogenes
53. Bacterial interference: Its effect on nursery-acquired infection with Staphylococcus aureus. I. Preliminary observations on artificial colonization of newborns
54. Bacterial interference: Its effect on nursery-acquired infection with Staphylococcus aureus. II. The Ohio epidemic
55. Bacterial interference: Its effect on nursery-acquired infection with Staphylococcus aureus. III. The Georgia epidemic
56. Bacterial interference: Its effect on nursery-acquired infection with Staphylococcus aureus. IV. The Louisiana epidemic
57. Control of a staphylococcal outbreak in a nursery: Use of bacterial interference
58. Use of bacterial interference to control a staphylococcal nursery outbreak: Deliberate colonization of all infants with a 502A strain of Staphylococcus aureus
59. Bacterial interference among strains of Staphylococcus aureus in man
60. Bacterial interference. Protection against recurrent intrafamilial staphylococcal disease
61. Fatal septicemia due to Staphylococcus aureus 502A. Report of a case and review of the infectious complications of bacterial interference programs
62. Bacterial interference caused by autoinducing peptide variants
63. Bacterial interference among nasal inhabitants: Eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp
64. 2 produced by viridans group Streptococci may contribute to inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns
65. Inhibition of methicillin-resistant Staphylococcus aureus colonization of oral cavities in newborns by viridans group Streptococci
66. MSCRAMM-mediated adherence of microorganisms to host tissues
67. Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin
68. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus
69. Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus
70. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus
71. Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: Use of this peptide sequence in the synthesis of biologically active peptides
72. Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene
73. Isolation of an adhesin from Staphylococcus aureus that binds Lewis a blood group antigen and its relevance to sudden infant death syndrome
74. Development and characterization of a Staphylococcus aureus nasal colonization model in mice